> Skip repeated content
iris-navarro-millan-headshot.jpg

Iris Navarro-Millan, MD


Rheumatology
iris-navarro-millan-headshot.jpg

Iris Navarro-Millan, MD


Hospital for Special Surgery
535 East 70th Street
New York, NY, 10021

212.774.7548
Hospital for Special Surgery
535 East 70th Street
New York, NY, 10021

212.774.7548

Dr. Navarro-Millan is a rheumatologist with expertise in rheumatoid arthritis. She has more than 5 years of experience in the field. Her background gives her expertise working with different populations and to provide sensitive and compassionate care for her patients. This care is focused on empowering patients to participate in their treatment decision making and overall care.

She is a member of the American College of Rheumatology (ACR) and has served as an ad hoc journal reviewer for: Arthritis & Rheumatism, Journal of Rheumatology, Arthritis Care and Research, Seminars in Arthritis and Rheumatism and Arthritis Research & Therapy.

She is a clinical researcher and her research is directed towards rheumatoid arthritis. She is funded by the NIH to conduct clinical and patient–centered research focus in cardiovascular risk reduction among patients with rheumatoid arthritis.

Back in the Game Patient Stories

Appointments

Assistant Attending Physician, Hospital for Special Surgery
Assistant Professor, Weill Cornell Medical College
Assistant Professor, NewYork-Presbyterian Hospital

Specialty

Procedures

Arthrocentesis
Intra-articular joint injections
Tendon sheath injections

Awards

K23 NIH award - NIAMS - Optimization of hyperlipidemia management in patients with rheumatoid arthritis
Disease Targeted Innovative Research Award - Rheumatology Research Foundation, 2014
Comprehensive Arthritis, Musculoskeletal, and Autoimmunity Center at the University of Alabama at Birmingham (CAMAC) Research Day, First Place, Junior Faculty, 2014
Gene V Ball Award for best case presentation, University of Alabama at Birmingham, 2011

Languages

Spanish

Insurance Information


Please do not hesitate to contact our office if you have questions regarding your insurance coverage. You may still have coverage subject to the availability of 'out-of-network' benefits.

Education

Universidad Autonoma de Guadalajara, Jalisco Mexico, 2005

Internship

Carraway Methodist Medical Center, Birmingham, Alabama, 2008-2009

Residency

Carraway Methodist Medical Center, Birmingham, Alabama
Baptist Health System, Birmingham, Alabama, 2009

Fellowship

University of Alabama at Birmingham, 2012

Certification

Board Certified in Internal Medicine 2009-2019
Board Certified in Rheumatology 2011-2021

State Licensure

New York

Selected Books/Chapters

Navarro-Millán IY, Alarcón G S: "Lippincott's Primary Care Rheumatology." Book Chapter: "Overlap Syndromes and Unclassified or Undifferentiated Connective Tissue Disease" Lippincott, Williams & Wilkins. 2011: ISBN/ISSN: 9781609138080.

Selected Publications

Navarro-Millán I, Yang S, DuVall SL, Chen L, Baddley J, Cannon GW, Delzell ES, Zhang J, Safford M, Patkar NM, Mikuls TR, Singh JA, Curtis JR. Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration. Ann Rheum Dis. Feb 2016;75(2):341-347. PMCID: PMC4752663

Navarro-Millán I, Charles-Schoeman C, Yang S, Bathon J, Bridges L, Chen L, Cofield S, Dell'talia LJ, Moreland L, O'Dell JR, Paulus HE, Curtis JR. 2013. Changes in Lipoproteins Associated with MTX, MTX + Etanercept, and Triple DMARD Therapy among Early RA Patients in the TEAR Trial. Arthritis Rheum. 65(6):1430-8. PMCID: PMC3672346.

Charles-Schoeman C, Wang X, Lee YY, Shahbazian A, Navarro-Millán I, Yang S, Chen L, Cofield SS, Moreland LW, O'Dell J, Bathon J, Paulus H, Bridges SL Jr, Curtis JR. Association of Triple Therapy with Improvement in Cholesterol Profiles over Two Year Follow-up in the TEAR Trial. Arthritis Rheumatol. 2016 Mar;68(3):577-86. PMCID: PMC4774543.

Navarro-Millán I, Herrinton L, Chen L, Liyan L, Curtis JR. Comparative Effectiveness of Etanercept and Adalimumab in Patient Reported Outcomes and Injection-Related Tolerability. PloS one. 2016;11(3):e0149781. PMCID: PMC4805235

Navarro-Millán I, Chen L, Greenberg J, Pappas DA, Curtis JR. 2013. Predictors and Persistence of new-onset clinical remission in rheumatoid arthritis patients. Semin Arthritis Rheum 43(2):137-143. PMCID: PMC4184191.

Navarro-Millán I, Singh JA, Curtis JR. 2012. Systematic review of tocilizumab for Rheumatoid Arthritis: A New Biologic Targeting the Interleukin-6 Receptor. Clin Ther 34(4):788-802.e3. PMCID: PMC3805022

Navarro-Millán I, Sattui SE, Curtis JR. 2013. Systematic Review of Tumor Necrosis Factor Inhibitor Discontinuation Studies in Rheumatoid Arthritis. Clin Ther 35(11):1850-1861 e1. PMCID: PMC3917677

Navarro-Millán I, Curtis JR. 2013. Newest clinical trial results with antitumor necrosis factor and non-anti-tumor necrosis factor biologics for rheumatoid arthritis. Curr Opin Rheumatol 25(3):384-90. PMCID: PMC4041208

Navaro-Millán I, Darrah E, Westfall AO, Mikuls TE, Reynolds RJ, Danila MI, Curtis JR, Bridges SL. Association of Anti-Peptidyl Arginine Deiminase Antibodies with Radiographic Severity of Rheumatoid Arthritis in African Americans. Arthritis Res Ther. 2016 Oct 22;18(1):241. PMCID: PMC5075170

Costenbader KH, Khamashta M, Ruiz-Garcia S, Perez-Rodriguez MT, Petri M, Elliott J, Manzi S, Karlson EW, Turner-Stokes T, Bermas B, Coblyn J, Massarotti E, Schur P, Fraser P, Navarro I, Hanly JG, Shaver TS, Katz RS, Chakravarty E, Fortin PR, Sanchez ML, Liu J, Michaud K, Alarcón GS, Wolfe F. 2010. Development and initial validation of a self-assessed lupus organ damage instrument. Arthritis Care Res. 62(4):559-68. PMCID: PMC 3179258.

For more publications, please the PubMed listing.

Selected Presentations

5/2012 6th National Young Research Investigator Forum, "American College of Rheumatology Annual Scientific Meeting, "Application of the New American College of Rheumatology/European League Against Rheumatism Rheumatoid Arthritis Remission Criteria in a United States Cohort" (Abstract Oral presentation) Destin, FL

9/2014 Comprehensive Arthritis, Musculoskeletal, and Autoimmunity Center (CAMAC) Research Day. "Association of Anti-Peptidyl Arginine Deiminase Antibodies with Radiographic Severity of Rheumatoid Arthritis in African Americans" (Abstract Oral Presentation) Birmingham, AL

4/2016 "Using Rheumatoid Arthritis Clinical Outcomes to Develop Patient Centered Research Questions" National Institutes of Health-National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) – Grand Rounds. Bethesda, Maryland

7/2016 "PROs in Rheumatoid Arthritis: Electronic Data Capture to Improve Patient Outcomes" Investigators Meeting –Rheumatology Research Foundation. Atlanta, GA